{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:21:35Z","timestamp":1760908895053},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,6]],"date-time":"2014-05-06T00:00:00Z","timestamp":1399334400000},"content-version":"vor","delay-in-days":125,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["idcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1016\/j.idcr.2014.04.002","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T17:16:21Z","timestamp":1401383781000},"page":"32-35","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Three cases of presumed pneumocystis pneumonia in patients receiving bortezomib therapy for multiple myeloma"],"prefix":"10.1016","volume":"1","author":[{"given":"Christopher D.","family":"Swan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair B.","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2014.04.002_bib0005","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1001\/archinte.1995.00430220094010","article-title":"Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases","volume":"155","author":"Arend","year":"1995","journal-title":"Arch Intern Med"},{"issue":"September (9)","key":"10.1016\/j.idcr.2014.04.002_bib0010","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1183\/09031936.95.08091548","article-title":"Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients","volume":"8","author":"Ewig","year":"1995","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.idcr.2014.04.002_bib0015","doi-asserted-by":"crossref","first-page":"663","DOI":"10.7326\/0003-4819-100-5-663","article-title":"Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies","volume":"100","author":"Kovacs","year":"1984","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.idcr.2014.04.002_bib0020","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1378\/chest.118.3.704","article-title":"Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states","volume":"118","author":"Mansharamani","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.idcr.2014.04.002_bib0025","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/QCO.0b013e32834cac17","article-title":"Pneumocystis jirovecii pneumonia in non-HIV-infected patients: new risks and diagnostic tools","volume":"24","author":"Reid","year":"2011","journal-title":"Curr Opin Infect Dis"},{"issue":"8","key":"10.1016\/j.idcr.2014.04.002_bib0030","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.idcr.2014.04.002_bib0035","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M","article-title":"Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality","volume":"42","author":"Ward","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.idcr.2014.04.002_bib0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.idcr.2014.04.002_bib0045","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1378\/chest.08-1309","article-title":"Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates","volume":"135","author":"Azoulay","year":"2009","journal-title":"Chest"},{"issue":"May (9)","key":"10.1016\/j.idcr.2014.04.002_bib0050","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1182\/blood-2005-11-4541","article-title":"Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma","volume":"107","author":"Miyakoshi","year":"2006","journal-title":"Blood"},{"issue":"October (2)","key":"10.1016\/j.idcr.2014.04.002_bib0055","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1365-2141.2004.05188.x","article-title":"A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma","volume":"127","author":"Jagannath","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.idcr.2014.04.002_bib0060","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2559.2009.03263.x","article-title":"Interstitial pneumonitis caused by Pneumocystis jirovecii pneumonia (PCP) during bortezomib treatment","volume":"54","author":"Wondergem","year":"2009","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.idcr.2014.04.002_bib0065","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s15010-007-7191-8","article-title":"Evaluation of toluidine blue O staining for the diagnosis of Pneumocystis jirovecii in expectorated sputum sample and bronchoalveolar lavage from HIV-infected patients in a tertiary care referral center in Ethiopia","volume":"36","author":"Aderaye","year":"2008","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.idcr.2014.04.002_bib0070","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000327625","article-title":"Bronchoalveolar lavage fluid cytology in patients with Pneumocystis carinii pneumonia","volume":"45","author":"Jacobs","year":"2001","journal-title":"Acta Cytol"},{"key":"10.1016\/j.idcr.2014.04.002_bib0075","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1164\/ajrccm\/140.5.1204","article-title":"Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS","volume":"140","author":"Limper","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.idcr.2014.04.002_bib0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.4065\/71.1.102","article-title":"Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: who should receive prophylaxis","volume":"71","author":"Sepkowitz","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.idcr.2014.04.002_bib0085","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/archinte.1995.00430110015002","article-title":"Pneumocystis carinii pneumonia without acquired immunodeficiency syndrome: more patients, same risk","volume":"155","author":"Sepkowitz","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.idcr.2014.04.002_bib0090","unstructured":"MIMS Online. https:\/\/www.mimsonline.com.au [Accessed 29.03.14]."},{"issue":"29","key":"10.1016\/j.idcr.2014.04.002_bib0095","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1200\/JCO.2007.14.9641","article-title":"Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study","volume":"26","author":"Chanan-Khan","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.idcr.2014.04.002_bib0100","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3816\/CLM.2008.n.031","article-title":"Bortezomib and the increased incidence of herpes zoster in patients with multiple myeloma","volume":"8","author":"Kim","year":"2008","journal-title":"Clin Lymph Myeloma"},{"issue":"6","key":"10.1016\/j.idcr.2014.04.002_bib0105","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood-2012-10-459883","article-title":"Carfilzomib","volume":"121","author":"Kortuem","year":"2013","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.idcr.2014.04.002_bib0110","first-page":"47","article-title":"Treatment of Pneumocystis carinii pneumonitis with trimethoprim-sulfamethoxazole","volume":"112","author":"Hughes","year":"1975","journal-title":"Can Med Assoc J"},{"issue":"2","key":"10.1016\/j.idcr.2014.04.002_bib0115","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1378\/chest.128.2.573","article-title":"Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features","volume":"128","author":"Festic","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.idcr.2014.04.002_bib0120","series-title":"Clinical practice guidelines in oncology. Prevention and treatment of cancer-related infections. Version 1.2013","author":"National Comprehensive Cancer Network (NCCN)","year":"2014"},{"issue":"9","key":"10.1016\/j.idcr.2014.04.002_bib0125","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.4065\/82.9.1052","article-title":"Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials","volume":"82","author":"Green","year":"2007","journal-title":"Mayo Clin Proc"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250914000110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250914000110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T19:50:49Z","timestamp":1689277849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250914000110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"alternative-id":["S2214250914000110"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2014.04.002","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three cases of presumed pneumocystis pneumonia in patients receiving bortezomib therapy for multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2014.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2014 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}